• Michael Knaap resigns as CEO and Managing Director of Monash IVF Group
• Malik Jainudeen appointed as Acting CEO
• Malik Jainudeen has over a decade of experience with Monash IVF Group

Monash IVF Group Limited (ASX:MVF) has announced that the Board has accepted the resignation of Michael Knaap as Chief Executive Officer and Managing Director. Mr. Knaap has also resigned as a director of Monash IVF Group Limited. The Board acknowledges and respects his decision. Since his appointment in 2019, Michael has led the organisation through a period of significant growth and transformation, and the Board thanks him for his years of dedicated service. Monash IVF Group Chief Financial Officer and Company Secretary, Malik Jainudeen has been appointed as Acting Chief Executive Officer. Malik Jainudeen brings over a decade of service to Monash IVF Group, having joined in 2014 and serving as Chief Financial Officer and Company Secretary since 2019. His deep understanding of the organisation's operations positions him as a steady and capable leader during this transitional period. Malik Jainudeen's remuneration will remain as stated on page 57 of the 2024 Annual Report until further notice.